Anheuser-Busch Is Quietly Making Believers Out of Skeptics

Signal: BUY | Score: 64.52/100

BUD has put together back-to-back earnings beats in 2026 and the stock is still trading 3% below its 52-week high. The market hasn't fully priced in what's clearly a turnaround story gaining real traction. At $83.89, this is one of the cleaner setups in Consumer Defensive right now.

The Setup

BUD is consolidating just under its 52-week high of $86.60, which is exactly the kind of coiling action you want to see before a breakout. RSI sits at 54.3 - not overbought, not overextended, just healthy momentum building. The momentum score of 71.5 is the strongest component of this pick, confirming that price action has been trending in the right direction without getting frothy. With a beta of 0.79, you're getting upside participation with below-market volatility. That's a rare combo.

The Catalyst

The story here is straightforward. On July 30, 2026, AB InBev dropped Q2 results that genuinely surprised the street - EPS of $1.21 against estimates of $1.09 to $1.12, and revenue of $16.66 billion versus the $16.33 to $16.39 billion consensus expected. That's 11% year-over-year revenue growth. And it wasn't a one-quarter fluke. Q1 2026 told the same story: EPS of $0.97 beating the $0.90 to $0.91 estimate, with 12% revenue growth year over year. Two consecutive beats with accelerating fundamentals, and the stock hasn't broken out yet. The next earnings date is October 29, giving you 83 days of runway for this thesis to play out.

Bull Case

Analyst consensus target sits at $97.03, representing roughly 15.7% upside from current levels - that's a meaningful gap to close.
Two consecutive earnings beats with double-digit revenue growth signal a genuine operational recovery, not a one-time event.
Trading at a forward PE of 16.86 in a defensive sector with 1.6% dividend yield, the valuation still has room to re-rate higher as confidence builds.

Bear Case

Debt-to-equity of 71.88 is heavy, and any interest rate surprises or demand softness could pressure margins fast.
Sentiment score of 50.0 is dead neutral - there's no crowd momentum behind this yet, which means a catalyst delay could keep the stock range-bound for longer than expected.

The Trade

Entry: $83.89
Target: $97.00 (in line with analyst consensus)
Stop Loss: $77.50 (just below the 10% drawdown level)
Risk/Reward: Approximately 2.0:1
Timeframe: 60 to 90 days, with Q3 earnings on October 29 as the natural checkup point

*This is one person's analysis, not financial advice. Always do your own research.*